Form 4: Natera Co-Founder Sells Over $800K in Stock

Jonathan Sheena, Co-Founder and Director of Natera, Inc., reported the sale of 4,570 shares of common stock totaling approximately $807,235 through pre-arranged 10b5-1 trading plans.

Summary

• Jonathan Sheena, a Co-Founder and Director of Natera, Inc. (NTRA), reported multiple sales of the company's common stock.
• On October 15, 2025, Sheena directly sold a total of 3,070 shares of common stock at weighted average prices ranging from $172.9918 to $176.6252 per share.
• These direct sales were executed pursuant to a Rule 10b5-1 trading plan adopted on December 11, 2024.
• Following these direct transactions, Sheena's direct beneficial ownership stands at 236,112 shares.
• On October 17, 2025, an additional 1,500 shares were sold indirectly through two trusts: 750 shares by Caraluna 1 Trust and 750 shares by Caraluna 2 Trust.
• The indirect sales were made at weighted average prices ranging from $178.5818 to $179.3511 per share.
• These indirect sales were executed pursuant to a Rule 10b5-1 trading plan adopted on June 7, 2024.
• The reporting person disclaims beneficial ownership over the securities held by the Caraluna trusts.
• The total value of shares sold across all transactions is approximately $807,235.85.

Sentiment

Score: 4

Explanation: The sentiment is moderately negative due to a significant insider sale by a co-founder and director, even though it was executed under a pre-arranged 10b5-1 plan. Such sales can sometimes be interpreted by the market as a signal, despite the pre-planned nature.

Negatives

• The sale of shares by a co-founder and director, even under a pre-arranged plan, could be perceived negatively by investors, potentially signaling a lack of confidence or a desire to diversify personal holdings.
• The total value of shares sold, approximately $807,235, represents a notable divestment by a key insider.

Risks

• Potential for negative investor sentiment or market reaction due to insider selling, which could put downward pressure on the stock price.
• Reduced alignment of interests between the co-founder/director and common shareholders as personal equity stake decreases.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding Natera's future financial performance or strategic outlook.

Industry Context

This filing is a standard insider transaction report and does not provide information directly related to broader industry trends or competitive landscape. It reflects an individual's personal trading activity within the company.

Related Party Transactions

• Sales of 1,500 shares were made indirectly through Caraluna 1 Trust and Caraluna 2 Trust, for which the reporting person disclaims beneficial ownership. These are standard disclosures for insider transactions involving trusts.

Stakeholder Impact

• Shareholders may interpret the insider selling as a negative signal, potentially impacting investor confidence and the company's stock valuation.
• Employees and other stakeholders might monitor such transactions for insights into management's perspective on the company's future.

Key Dates

Keywords

Natera, NTRA, Insider Trading, Form 4, Stock Sale, Director, Co-Founder, 10b5-1 Plan, Equity Transaction